Editorial
doi: 10.1097/01.gme.0000196814.41871.ff.
Hormone therapy and breast cancer risk: trumping fear with facts
- PMID: 16645526
- DOI: 10.1097/01.gme.0000196814.41871.ff
Item in Clipboard
Editorial
Hormone therapy and breast cancer risk: trumping fear with facts
Menopause.
2006 Mar-Apr.
No abstract available
Comment on
-
Hormone therapy and breast cancer: what factors modify the association?Menopause. 2006 Mar-Apr;13(2):178-84. doi: 10.1097/01.gme.0000177317.85887.65. Menopause. 2006. PMID: 16645531
Similar articles
-
The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.J Natl Cancer Inst. 2011 Feb 16;103(4):284-5. doi: 10.1093/jnci/djq561. Epub 2011 Jan 28. J Natl Cancer Inst. 2011. PMID: 21278357 No abstract available.
-
Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.J Natl Cancer Inst. 2011 Jul 6;103(13):1069; reply 1069-70. doi: 10.1093/jnci/djr191. Epub 2011 Jun 23. J Natl Cancer Inst. 2011. PMID: 21700925 No abstract available.
-
Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.J Natl Cancer Inst. 2007 Dec 5;99(23):1815; author reply 1816-7. doi: 10.1093/jnci/djm209. Epub 2007 Nov 27. J Natl Cancer Inst. 2007. PMID: 18042938 No abstract available.
-
[Present status concerning hormone replacement therapy in menopause and the risk of breast cancer].J Gynecol Obstet Biol Reprod (Paris). 1998 Oct;27(1 Suppl):12-6. J Gynecol Obstet Biol Reprod (Paris). 1998. PMID: 9864684 Review. French. No abstract available.
-
[Does menopausal hormonal replacement therapy increase the risk of breast cancer?].Duodecim. 1996;112(12):1110-5. Duodecim. 1996. PMID: 10593013 Review. Finnish. No abstract available.
Cited by
-
Confronting the challenges of the menopausal transition.Womens Midlife Health. 2015 Oct 5;1:7. doi: 10.1186/s40695-015-0008-5. eCollection 2015. Womens Midlife Health. 2015. PMID: 30766694 Free PMC article. Review.
-
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.Endocr Rev. 2013 Apr;34(2):171-208. doi: 10.1210/er.2012-1008. Epub 2012 Dec 13. Endocr Rev. 2013. PMID: 23238854 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
